مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

200
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

151
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

RELATIONSHIP BETWEEN CLOPIDOGREL‑RELATED POLYMORPHISMS AND VARIABLE PLATELET REACTIVITY AT 1 YEAR: A COHORT STUDY FROM HAN CHINESE

Pages

  0-0

Abstract

 Background: This study was designed to investigate the effect of CLOPIDOGREL-related gene POLYMORPHISMs on platelet reactivity and clinical outcome in Chinese Han patients. Materials and Methods: Three hundred and thirty-six percutaneous coronary intervention - treated patients were recruited and followed for 1 year. Blood samples were collected from all patients for DNA genotyping. The platelet reactivity unit was measured by the VERIFYNOW technique. The CYP2C19*2, CYP2C19*3, CYP2C19*17, ATP-binding cassette subfamily B member 1, ITGB3, CYP2C9*3, CYP2B6*9, and P2Y12 alleles were assessed.Results: The clinical endpoints were related to previous heart disease history (11.90% vs.28.57%, P=0.017), stroke (12.24% vs.16.67%, P=0.039), and diabetes (27.55% vs.52.38%, P=0.047). High on-treatment platelet reactivity (HTPR) was frequent in advanced age (P=0.019), male gender (P=0.016), hypertension (P=0.033), and chronic renal failure (P=0.040). There were more endpoints in the CYP2C19*2 and P2Y12 mutant carriers (76.19% vs.43.20%, P<0.001; 50.00% vs.35.71%, P=0.001, respectively), whereas fewer in the CYP2C19*17 mutant carriers (11.90% vs.56.46%, P=0.001). CYP2C19*2 and P2Y12 POLYMORPHISM manifested HTPR (194.25 ± 45.91 vs.151.38 ± 58.14, P<0.001; 180.33 ± 67.25 vs.161.89 ± 56.49, P=0.008, respectively), whereas CYP2C19*17 mutant improved platelet reactivity (97.17 ± 45.38 vs.169.08 ± 57.15, P=0.003). However, there were no further cardiovascular deaths in endpoint patients.Conclusion: In Han Chinese people of mainland China, CLOPIDOGREL-related gene POLYMORPHISMs are related to variable platelet reactivity after CLOPIDOGREL maintenance dosing, which influences major adverse cardiovascular events, without an effect on cardiac death.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    XIAODONG, WANG, Lai, Yan, Luo, Yu, Zhang, Xumin, Zhou, Hua, Ye, Zi, Tang, Jiani, & Liu, Xuebo. (2016). RELATIONSHIP BETWEEN CLOPIDOGREL?RELATED POLYMORPHISMS AND VARIABLE PLATELET REACTIVITY AT 1 YEAR: A COHORT STUDY FROM HAN CHINESE. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 21(8), 0-0. SID. https://sid.ir/paper/690784/en

    Vancouver: Copy

    XIAODONG WANG, Lai Yan, Luo Yu, Zhang Xumin, Zhou Hua, Ye Zi, Tang Jiani, Liu Xuebo. RELATIONSHIP BETWEEN CLOPIDOGREL?RELATED POLYMORPHISMS AND VARIABLE PLATELET REACTIVITY AT 1 YEAR: A COHORT STUDY FROM HAN CHINESE. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2016;21(8):0-0. Available from: https://sid.ir/paper/690784/en

    IEEE: Copy

    WANG XIAODONG, Yan Lai, Yu Luo, Xumin Zhang, Hua Zhou, Zi Ye, Jiani Tang, and Xuebo Liu, “RELATIONSHIP BETWEEN CLOPIDOGREL?RELATED POLYMORPHISMS AND VARIABLE PLATELET REACTIVITY AT 1 YEAR: A COHORT STUDY FROM HAN CHINESE,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 21, no. 8, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/690784/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button